183 related articles for article (PubMed ID: 7970933)
1. Bone marrow transplantation has a significant effect on enzyme levels and storage of glycosaminoglycans in tissues and in isolated hepatocytes of mucopolysaccharidosis type VII mice.
Poorthuis BJ; Romme AE; Willemsen R; Wagemaker G
Pediatr Res; 1994 Aug; 36(2):187-93. PubMed ID: 7970933
[TBL] [Abstract][Full Text] [Related]
2. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates.
Sands MS; Barker JE; Vogler C; Levy B; Gwynn B; Galvin N; Sly WS; Birkenmeier E
Lab Invest; 1993 Jun; 68(6):676-86. PubMed ID: 8515654
[TBL] [Abstract][Full Text] [Related]
3. Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery.
Richard M; Arfi A; Seguin J; Gandolphe C; Scherman D
Gene Ther; 2009 Jun; 16(6):746-56. PubMed ID: 19357715
[TBL] [Abstract][Full Text] [Related]
4. Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival.
Vogler C; Sands MS; Levy B; Galvin N; Birkenmeier EH; Sly WS
Pediatr Res; 1996 Jun; 39(6):1050-4. PubMed ID: 8725268
[TBL] [Abstract][Full Text] [Related]
5. Delivery of a retroviral vector expressing human beta-glucuronidase to the liver and spleen decreases lysosomal storage in mucopolysaccharidosis VII mice.
Gao C; Sands MS; Haskins ME; Ponder KP
Mol Ther; 2000 Sep; 2(3):233-44. PubMed ID: 10985954
[TBL] [Abstract][Full Text] [Related]
6. Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer.
Wolfe JH; Sands MS; Barker JE; Gwynn B; Rowe LB; Vogler CA; Birkenmeier EH
Nature; 1992 Dec 24-31; 360(6406):749-53. PubMed ID: 1465145
[TBL] [Abstract][Full Text] [Related]
7. Enzyme replacement in murine mucopolysaccharidosis type VII: neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy.
Vogler C; Levy B; Galvin NJ; Thorpe C; Sands MS; Barker JE; Baty J; Birkenmeier EH; Sly WS
Pediatr Res; 1999 Jun; 45(6):838-44. PubMed ID: 10367775
[TBL] [Abstract][Full Text] [Related]
8. Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts.
Moullier P; Bohl D; Heard JM; Danos O
Nat Genet; 1993 Jun; 4(2):154-9. PubMed ID: 8348154
[TBL] [Abstract][Full Text] [Related]
9. Widespread correction of lysosomal storage following intrahepatic injection of a recombinant adeno-associated virus in the adult MPS VII mouse.
Sferra TJ; Backstrom K; Wang C; Rennard R; Miller M; Hu Y
Mol Ther; 2004 Sep; 10(3):478-91. PubMed ID: 15336648
[TBL] [Abstract][Full Text] [Related]
10. Early onset of lysosomal storage disease in a murine model of mucopolysaccharidosis type VII: undegraded substrate accumulates in many tissues in the fetus and very young MPS VII mouse.
Vogler C; Levy B; Galvin N; Lessard M; Soper B; Barker J
Pediatr Dev Pathol; 2005; 8(4):453-62. PubMed ID: 16222480
[TBL] [Abstract][Full Text] [Related]
11. Brain transplantation of genetically modified bone marrow stromal cells corrects CNS pathology and cognitive function in MPS VII mice.
Sakurai K; Iizuka S; Shen JS; Meng XL; Mori T; Umezawa A; Ohashi T; Eto Y
Gene Ther; 2004 Oct; 11(19):1475-81. PubMed ID: 15295619
[TBL] [Abstract][Full Text] [Related]
12. Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells.
Ross CJ; Bastedo L; Maier SA; Sands MS; Chang PL
Hum Gene Ther; 2000 Oct; 11(15):2117-27. PubMed ID: 11044913
[TBL] [Abstract][Full Text] [Related]
13. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation.
Birkenmeier EH; Barker JE; Vogler CA; Kyle JW; Sly WS; Gwynn B; Levy B; Pegors C
Blood; 1991 Dec; 78(11):3081-92. PubMed ID: 1954394
[TBL] [Abstract][Full Text] [Related]
14. Correction of murine mucopolysaccharidosis VII by a human beta-glucuronidase transgene.
Kyle JW; Birkenmeier EH; Gwynn B; Vogler C; Hoppe PC; Hoffmann JW; Sly WS
Proc Natl Acad Sci U S A; 1990 May; 87(10):3914-8. PubMed ID: 2111021
[TBL] [Abstract][Full Text] [Related]
15. Enzyme replacement therapy for murine mucopolysaccharidosis type VII.
Sands MS; Vogler C; Kyle JW; Grubb JH; Levy B; Galvin N; Sly WS; Birkenmeier EH
J Clin Invest; 1994 Jun; 93(6):2324-31. PubMed ID: 8200966
[TBL] [Abstract][Full Text] [Related]
16. Enzyme replacement with recombinant beta-glucuronidase in the newborn mucopolysaccharidosis type VII mouse.
Vogler C; Sands M; Higgins A; Levy B; Grubb J; Birkenmeier EH; Sly WS
Pediatr Res; 1993 Dec; 34(6):837-40. PubMed ID: 8108204
[TBL] [Abstract][Full Text] [Related]
17. Expression in blood cells may contribute to biochemical and pathological improvements after neonatal intravenous gene therapy for mucopolysaccharidosis VII in dogs.
Wang B; O'Malley TM; Xu L; Vite C; Wang P; O'Donnell PA; Ellinwood NM; Haskins ME; Ponder KP
Mol Genet Metab; 2006 Jan; 87(1):8-21. PubMed ID: 16275036
[TBL] [Abstract][Full Text] [Related]
18. Glycosaminoglycan storage in cultured neonatal murine mucopolysaccharidosis type VII neuroglial cells and correction by beta-glucuronidase gene transfer.
Taylor RM; Wolfe JH
J Neurochem; 1997 May; 68(5):2079-85. PubMed ID: 9109535
[TBL] [Abstract][Full Text] [Related]
19. Genetic correction of the fetal brain increases the lifespan of mice with the severe multisystemic disease mucopolysaccharidosis type VII.
Karolewski BA; Wolfe JH
Mol Ther; 2006 Jul; 14(1):14-24. PubMed ID: 16624622
[TBL] [Abstract][Full Text] [Related]
20. Gene transfer of low levels of beta-glucuronidase corrects hepatic lysosomal storage in a large animal model of mucopolysaccharidosis VII.
Wolfe JH; Sands MS; Harel N; Weil MA; Parente MK; Polesky AC; Reilly JJ; Hasson C; Weimelt S; Haskins ME
Mol Ther; 2000 Dec; 2(6):552-61. PubMed ID: 11124056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
